Bio-Path Holdings (BPTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 188 | 1,052 | 2,352 | 3,444 | 6,731 |
| Other current assets | 817 | 1,358 | 1,818 | 1,746 | 1,664 |
| TOTAL | $1,637 | $3,042 | $4,802 | $6,259 | $10,791 |
| Non-Current Assets | |||||
| PPE Net | 54 | 76 | 92 | 114 | 136 |
| Other Non-Current Assets | 77 | 102 | 127 | 151 | 175 |
| TOTAL | $131 | $178 | $219 | $265 | $311 |
| Total Assets | $1,768 | $3,220 | $5,021 | $6,524 | $11,102 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,746 | 457 | 277 | 638 | 827 |
| Accrued Expenses | 1,984 | 1,346 | 964 | 675 | 973 |
| TOTAL | $3,812 | $1,906 | $1,357 | $1,426 | $1,910 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 581 | 873 | 1,139 | 55 | 85 |
| TOTAL | $581 | $873 | $1,139 | $55 | $85 |
| Total Liabilities | $4,393 | $2,779 | $2,496 | $1,481 | $1,995 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,656 | 679 | 618 | 573 | 398 |
| Common Shares | 1 | 1 | 11 | 8 | 8 |
| Retained earnings | -110,764 | -107,607 | -104,235 | -101,036 | -96,802 |
| TOTAL | $-2,625 | $441 | $2,525 | $5,043 | $9,107 |
| Total Liabilities And Equity | $1,768 | $3,220 | $5,021 | $6,524 | $11,102 |